About 54,000 workers in the EU are estimated to be potentially exposed to acrylamide. The occupational exposure to acrylamide is primarily from dermal contact with the solid monomer and inhalation of dust and vapor during acrylamide and polyacrylamide production.
Its exposure increases the risk for several types of cancer (classified as group 2A by IARC i.e. probable human carcinogens). In the body, acrylamide is converted to a compound called glycidamide, which causes mutations and damage to DNA. The high levels of occupational acrylamide exposure may also cause neurological damage. However, studies of occupational exposure are currently limited and inconclusive.
Where risks occur
More about the substance
How symptoms can affect you
What you can do
Solutions and good practices:
Download the factsheet:
References: cancer.gov, EFSA, IARC, EC, NIOSH, OSHA, CAREX